10x Genomics, Inc.

BST:1KJ Stock Report

Market Cap: €879.1m

10x Genomics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BST:1KJ Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
24 Feb 25Sell€53,816Serge SaxonovIndividual5,092€10.57
24 Feb 25Sell€48,331Benjamin HindsonIndividual4,573€10.57
21 Feb 25Buy€426,323Alan MateoIndividual40,000€10.66
22 Nov 24Sell€76,465Benjamin HindsonIndividual5,807€13.17
22 Nov 24Sell€88,131Serge SaxonovIndividual6,693€13.17
22 Aug 24Sell€60,059Justin McAnearIndividual2,961€20.28
22 Aug 24Sell€88,253Benjamin HindsonIndividual4,351€20.28
22 Aug 24Sell€136,893Serge SaxonovIndividual6,749€20.28
22 May 24Sell€109,390Serge SaxonovIndividual4,877€22.43
22 May 24Sell€65,854Justin McAnearIndividual2,936€22.43
22 May 24Sell€91,671Benjamin HindsonIndividual4,087€22.43

Insider Trading Volume

Insider Buying: 1KJ insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1KJ?
Owner TypeNumber of SharesOwnership Percentage
State or Government46,3450.0376%
General Public5,968,6334.85%
Individual Insiders9,866,8368.01%
Institutions107,251,93687.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 77.69% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.3%
FMR LLC
17,656,269€126.1m-3.65%0.01%
9.7%
ARK Investment Management LLC
11,944,057€85.3m11.1%0.85%
8.88%
The Vanguard Group, Inc.
10,933,549€78.1m-0.36%no data
5.42%
BlackRock, Inc.
6,667,822€47.6m-1.51%no data
4.49%
Millennium Management LLC
5,533,618€39.5m458%0.04%
4.36%
Nikko Asset Management Co., Ltd.
5,362,656€38.3m-6.14%0.02%
3.32%
Serge Saxonov
4,087,085€29.2m1.15%no data
2.66%
RA Capital Management, L.P.
3,279,401€23.4m0%0.38%
2.47%
Benjamin Hindson
3,039,005€21.7m-6.12%no data
2.2%
Morgan Stanley, Investment Banking and Brokerage Investments
2,714,412€19.4m107%no data
2%
John Stuelpnagel
2,457,823€17.5m0.68%no data
1.93%
UBS Asset Management AG
2,380,100€17.0m9.8%no data
1.63%
Citadel Advisors LLC
2,006,358€14.3m-27.8%0.02%
1.5%
Brown Capital Management, LLC
1,843,960€13.2m-16%0.27%
1.47%
Geode Capital Management, LLC
1,814,823€13.0m-0.05%no data
1.45%
T. Rowe Price Group, Inc.
1,781,268€12.7m-61.9%no data
1.44%
State Street Global Advisors, Inc.
1,774,992€12.7m1.39%no data
1.41%
Assenagon Asset Management S.A.
1,734,634€12.4m-5.32%0.02%
1.29%
Voloridge Investment Management, LLC
1,585,965€11.3m12.1%0.05%
1.22%
Deerfield Management Company, L.P. Series C
1,497,000€10.7m-0.79%0.26%
1.07%
Two Sigma Investments, LP
1,319,487€9.4m291%0.03%
1%
Two Sigma Advisers, LP
1,236,200€8.8m241%0.02%
0.99%
D. E. Shaw & Co., L.P.
1,218,598€8.7m0%0.01%
0.81%
Camber Capital Management LP
1,000,000€7.1m0%0.33%
0.64%
Capital Research and Management Company
793,300€5.7m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/07 00:43
End of Day Share Price 2025/05/02 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

10x Genomics, Inc. is covered by 19 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Luke SergottBarclays
Michael RyskinBofA Global Research
Kyle MiksonCanaccord Genuity